HOMOLOGOUS BLOOD TRANSFUSION: THE RISKS AND ALTERNATIVES
- 1 November 1994
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 88 (3) , 451-458
- https://doi.org/10.1111/j.1365-2141.1994.tb05059.x
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Predeposit autologous blood transfusion in patients with colorectal cancer: A feasibility studyBritish Journal of Surgery, 1992
- Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurityThe Journal of Pediatrics, 1991
- Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot studyThe Journal of Pediatrics, 1991
- Treatment of Transfusion-Dependent Anaemia of Chronic Renal Failure with Recombinant Human Erythropoietin: A European multicentre study in 142 patients to define dose regimen and safety profileNephrology Dialysis Transplantation, 1991
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- A Trial of Desmopressin (1-Desamino-8-D-Arginine Vasopressin) to Reduce Blood Loss in Uncomplicated Cardiac SurgeryNew England Journal of Medicine, 1989
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the “anemia of prematurity”The Journal of Pediatrics, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Fluosol-DA as a Red-Cell Substitute in Acute AnemiaNew England Journal of Medicine, 1986